Download pdf
The comparison of sodium sulfacetamide and erythromycin in treating trachoma
- 1 Wuhan Britain-China School
* Author to whom correspondence should be addressed.
Abstract
Trachoma is a common eye infection caused by Chlamydia trachomatis and there are many medicines for it already. Erythromycin is a type of antibiotic and sodium sulfacetamide is an antibacterial drug, they are both commonly used for treating trachoma. This passage contrasts the use of sodium sulfacetamide and erythromycin in the concepts of synthesis process, targets, and the resistance built up. Sodium sulfacetamide is a synthesized substance, generally contains 2 steps: prepare sulfacetamide and then let it hydrolysis to form the salt. It works by impede the synthesis of folic acids. If the Chlamydia tachomatis start to get folic acids from host cell, then sodium sulfacetamide can’t work any more. Erythromycin is produced by fermentation, it works by bind to ribosomes of the trachoma to impede synthesis of protein. The Chlamydiae can built up resistance by transporting erythromycin out, changing structure of their ribosomes, or destructing the erythromycin molecules. They don’t share many things in common, but the importance of them is significant, and they represents the main treatments of trachoma.
Keywords
trachoma, sodium sulfacetamide, erythromycin
[1]. Wang Ningli, Hu Ailian, Hugh R.Taylor, (2015), “Trachoma”
[2]. Liu Quanzhong, (2004), “Chlamydia and chlamydia diseases”
[3]. Liu Xiaodi, Ding Ling, (2017), “Novel progress on the prevention and treatment of trachoma”
[4]. David C W Mabey, Anthony W Solomon, Allen Foster, (2023), “Trachoma”, The Lancet
[5]. Jin Xiuying, Zhang Xiaolao, Zhang Wenhua, Wang Xianglan, Sun Xianli, Zhao Wei and Luo Shiyun (1980) “Pathogenesis of trachoma”, Chinese Medical Journal
[6]. Takudzwa Pound Chiwoneso, Nyashadzashe Mhlanga, Tafadzwa L Chisoko, Terrence Musayavanhu, (2023), “COMPARISONS IN THE SYNTHESIS OF SODIUM SULFACETAMIDE BY REFLUX AND ULTRASONIC IRRADIATION METHODS.”
[7]. H Fan, R C Brunham and G McClarty, (1992), “Acquisition and synthesis of folates by obligate intracellular bacteria of the genus Chlamydia.”, The Journal of Clinical Investigation
[8]. S. J. Duthie and A. Hawdon, (1998), “DNA instability (strand breakage, uracil misincorporation, and defective repair) is increased by folic acid depletion in human lymphocytes in vitro”, The FASEB Journal
[9]. Chi Qianzheng, (1985), “Selection of stabilizer and bacteriostatic agent of sulfonamide acetyl sodium eye drops”, Chinese Medical Journal
[10]. Li Lingling, Zhang Shaochang, Ma Qingjun, (2004), “The Antibacterial Effect of Erythromycin and the Mechanism of Erythromycin Resistance in Bacteria”
[11]. Bernard Weisblum, (1995), “Erythromycin Resistance by Ribosome Modification”, America Society for Microbiology
Cite this article
Bu,J. (2024). The comparison of sodium sulfacetamide and erythromycin in treating trachoma. Theoretical and Natural Science,45,94-101.
Data availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
Disclaimer/Publisher's Note
The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
About volume
Volume title: Proceedings of the 2nd International Conference on Modern Medicine and Global Health
© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and
conditions of the Creative Commons Attribution (CC BY) license. Authors who
publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons
Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this
series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published
version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial
publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and
during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See
Open access policy for details).